Elizabeth Hougen

(Ms. Elizabeth Hougen)

Positions

Position Company Period
Senior Vice President - Finance Akcea Therapeutics Inc Aug. 31, 2017 - Dec. 31, 2018
Chief Financial Officer Akcea Therapeutics Inc Jan. 1, 2015 - Aug. 31, 2017
Elizabeth Hougen's trades of Ionis Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-03 2025-01-31 S Sale
1,523 -1.4%
32.44
USD 49,404
1,523 -1.4% 32.44 USD 49,404
2025-01-17 2025-01-16 S Sale
8,870 -7.6%
32.81
USD 290,989
8,870 -7.6% 32.81 USD 290,989
2024-02-02 2024-02-02 S Sale
2,125 -2.2%
49.54
USD 105,272
2,125 -2.2% 49.54 USD 105,272
2024-01-18 2024-01-17 S Sale
8,683 -8.7%
50.42
USD 437,771
8,683 -8.7% 50.42 USD 437,771
2023-02-07 2023-02-06 S Sale
2,079 -2.7%
40.59
USD 84,392
2,079 -2.7% 40.59 USD 84,392
2023-01-19 2023-01-18 S Sale
8,280 -10.1%
39.70
USD 328,721
8,280 -10.1% 39.70 USD 328,721
2020-11-30 2020-11-25 PS Planned sale
21,680 -40.0%
50.05
USD 1,085,084
21,680 -40.0% 50.05 USD 1,085,084
2020-11-25 2020-11-24 PS Planned sale
4,320 -11.7%
50.83
USD 219,586
4,320 -11.7% 50.83 USD 219,586
2020-11-25 2020-11-23 PS Planned sale
5,875 -15.3%
50.11
USD 294,396
5,875 -15.3% 50.11 USD 294,396
2020-11-25 2020-11-23 PS Planned sale
13,125 -28.8%
50.11
USD 657,694
13,125 -28.8% 50.11 USD 657,694
2018-01-17 2018-01-16 S Sale
2,724 -15.8%
51.76
USD 140,994
2,724 -15.8% 51.76 USD 140,994
2017-01-18 2017-01-17 S Sale
623 -5.7%
46.29
USD 28,839
623 -5.7% 46.29 USD 28,839
2017-01-18 2017-01-17 S Sale
539 -5.5%
46.29
USD 24,951
539 -5.5% 46.29 USD 24,951
2017-01-18 2017-01-17 S Sale
733 -8.0%
46.29
USD 33,931
733 -8.0% 46.29 USD 33,931
// ... existing code ... // ... rest of the file ...